Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W N Kelly

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
American Journal of Hospital Pharmacy|September 1, 1986
Strategic planning for clinical services: panel discussionP G Pierpaoli, R W Anderson, W N Kelly, et al.
Clinical Pharmacology and Therapeutics|June 24, 2010
Quality of methods for assessing and reporting serious adverse events in clinical trials of cancer drugsS M Belknap, C H Georgopoulos, D P West, et al.
American Journal of Hospital Pharmacy|October 1, 1990
National survey of ethical issues presented to drug information centersW N Kelly, E C Krause, W J Krowinski, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2024
Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug EventsW N Kelly, M J Ho, T Smith, et al.
Acta Endocrinologica|January 1, 1974
Growth retardation in the Lesch-Nyhan syndromeJ S Skyler, F A Neelon, W J Arnold, et al.
Bulletin on the Rheumatic Diseases|January 1, 1978
The 1978 annual meeting of the American Rheumatism AssociationW N Kelly, P Barland, G G Bole, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
American Journal of Hospital Pharmacy|September 1, 1986
Strategic planning for clinical services: panel discussionP G Pierpaoli, R W Anderson, W N Kelly, et al.
Clinical Pharmacology and Therapeutics|June 24, 2010
Quality of methods for assessing and reporting serious adverse events in clinical trials of cancer drugsS M Belknap, C H Georgopoulos, D P West, et al.
American Journal of Hospital Pharmacy|October 1, 1990
National survey of ethical issues presented to drug information centersW N Kelly, E C Krause, W J Krowinski, et al.
Pharmacoepidemiology and Drug Safety|July 8, 2024
Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug EventsW N Kelly, M J Ho, T Smith, et al.
Acta Endocrinologica|January 1, 1974
Growth retardation in the Lesch-Nyhan syndromeJ S Skyler, F A Neelon, W J Arnold, et al.
Bulletin on the Rheumatic Diseases|January 1, 1978
The 1978 annual meeting of the American Rheumatism AssociationW N Kelly, P Barland, G G Bole, et al.
Pageof 4